XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
XORTX Therapeutics Inc. reported a decrease in total assets to $3.85 million as of September 30, 2024, compared to $5.47 million at the end of 2023, alongside an increased derivative warrant liability. The company’s current liabilities rose significantly, highlighting financial challenges amid ongoing research and development expenses.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
